Global Anticholinergic Drugs Market to Surpass a Valuation of USD 7,100 Mn By 2024
Market Research Future (MRFR) reports that the global anticholinergic drugs market will grow at a compound annual growth rate (CAGR) of 4.50% between 2016 and 2024, surpassing a valuation of USD 7,100 Mn. Rising prevalence of disorder associated with heart, muscle, central and peripheral nervous systems is influencing the global anticholinergic drugs market.
Free Sample PDF Available Here!! https://www.marketresearchfuture.com/sample_request/7895
Anticholinergic drugs are primarily used for treating nervous system disorders. These drugs are also used in treatment of several chronic diseases. Over the years, a slew of anticholinergic drugs has come up. Pharmaceutical companies are able to introduce new drugs with higher efficacy owing to advances in life science.
The growth of global geriatric population is linked with the rising incidence of CNS diseases. As per data released by World Health Organization (WHO), the world’s population aged 60 year and above is likely to grow twofold by the 2050. It is estimated that by 2023, over 20% of total population in the U.S. would be represented by people aged 65 years or above. At the same time, increased occurrence of chronic diseases is having a major influence on the global anticholinergic drugs market.
Despite being a popular category of drug, anticholinergic drugs remain under scepticism owing to associated side-effect. Stricter regulations are imposed on anticholinergic drugs dosage permit.
Global Anticholinergic Drugs Market: Competition Analysis
Pfizer Inc. (US), Astellas Pharma Inc. (Japan), Teva Pharmaceutical Industries Ltd (Israel), GlaxoSmithKline Plc (UK), Novartis AG (Switzerland), Allergan Plc (US), Sanofi (France), Johnson & Johnson Services Inc. (US), Mylan N.V. (US) and Boehringer Ingelheim International GmbH (Germany) are some of the key players discussed in MRFR’s report.
Global Anticholinergic Drugs Market: Segmental Analysis
The segmental analysis of the market has been conducted on the basis of product type, application, route of administration and end user.
Based on product type, the market has been segmented into semi-synthetic compound, synthetic compounds and natural. On the basis of application, the market has been segmented into Parkinson’s disease, muscle spasms, irritable bowel syndrome, overactive bladder and chronic obstructive pulmonary disease. Based on route of administration, the market has been segmented into topical, oral and parental. Based on end user, the market has been segmented into pharmacies and hospitals. The hospitals segment accounts for the largest market share. By the year 2024, the market is expected to reach a valuation of USD 4,200 Mn.
Global Anticholinergic Drugs Market: Regional Analysis
The report covers key regions like North America, Latin America, the Middle East & Africa (MEA), Europe and Asia Pacific (APAC). North America and Latin America collectively account for the largest market share in terms of revenue. The Americas is expected to retain its leading position throughout the assessment period. The growing geriatric population in the region coupled with increased prevalence of CNS diseases is expected to support the market growth during the forecast period. Demand for effective treatment options for CNS diseases has continued to grow in the region. Such factors are creating significant opportunities for the market.
Fuelled by rising incidence rate, the anticholinergic drugs market in Europe continue to grow at a substantial rate. Rising elderly population and high healthcare spending are a among the key factors supporting the market growth in Europe. In 2018, Germany accounted for 25.8% share of the market in Europe.
Asia Pacific is expected to demonstrate a healthy growth over the next couple of years. Rising healthcare standards, improving healthcare penetration and growing awareness level are some of the factors supporting the market growth in the region.
In the Middle East, the market growth is likely to be relatively slower as compared to other regions. However, introduction of new frameworks and economic growth in GCC countries is providing an impetus to the healthcare sector in the region.
OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/anticholinergic-drugs-market-7895
List Of Table
Table 1 List Of Assumptions 15
Table 2 Global Anticholinergic Drugs Market, By Type 2016-2024 (Usd Million) 32
Table 3 Global Anticholinergic Drugs Market For Synthetic Compounds, By Region, 2016–2024 (Usd Million) 32
Table 4 Global Anticholinergic Drugs Market For Natural, By Region, 2016–2024 (Usd Million) 33
Table 5 Global Anticholinergic Drugs Market For Semi-Synthetic Compounds, By Region, 2016–2024 (Usd Million) 33
Table 6 Global Anticholinergic Drugs Market, By Application 2016-2024 (Usd Million) 36
Table 7 Global Anticholinergic Drugs Market For Overactive Bladder, By Region, 2016–2024 (Usd Million) 36
Table 8 Global Anticholinergic Drugs Market For Parkinson’s Disease, By Region, 2016–2024 (Usd Million) 37
Table 9 Global Anticholinergic Drugs Market For Chronic Obstructive Pulmonary Disease (Copd), By Region,
2016–2024 (Usd Million) 37
Table 10 Global Anticholinergic Drugs Market For Muscle Spasms, By Region, 2016–2024 (Usd Million) 38
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.